Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study

被引:1330
作者
Sperber, Ami D. [1 ]
Bangdiwala, Shrikant, I [2 ,3 ]
Drossman, Douglas A. [4 ,5 ]
Ghoshal, Uday C. [6 ]
Simren, Magnus [7 ]
Tack, Jan [8 ]
Whitehead, William E. [9 ]
Dumitrascu, Dan L. [10 ]
Fang, Xuicai [11 ]
Fukudo, Shin [12 ]
Kellow, John [13 ]
Okeke, Edith [14 ]
Quigley, Eamonn M. M. [15 ,16 ]
Schmulson, Max [17 ]
Whorwell, Peter [18 ]
Archampong, Timothy [19 ]
Adibi, Payman [20 ]
Andresen, Viola [21 ]
Benninga, Marc A. [22 ]
Bonaz, Bruno [23 ]
Bor, Serhat [24 ]
Fernandez, Luis Bustos [25 ]
Choi, Suck Chei [26 ]
Corazziari, Enrico S. [27 ]
Francisconi, Carlos [28 ]
Hani, Albis [29 ]
Lazebnik, Leonid [30 ]
Lee, Yeong Yeh [31 ]
Mulak, Agata [32 ]
Rahman, M. Masudur [33 ]
Santos, Javier [34 ,35 ]
Setshedi, Mashiko [36 ]
Syam, Ari Fahrial [37 ]
Vanner, Stephen [38 ]
Wong, Reuben K. [39 ]
Lopez-Colombo, Aurelio [40 ]
Costa, Valeria [29 ]
Dickman, Ram [41 ]
Kanazawa, Motoyori [12 ]
Keshteli, Ammar Hassanzadeh [42 ]
Khatun, Rutaba [3 ]
Maleki, Iradj [43 ]
Poitras, Pierre [44 ]
Pratap, Nitesh [45 ]
Stefanyuk, Oksana [46 ]
Thomson, Sandie [36 ]
Zeevenhooven, Judith [22 ]
Palsson, Olafur S. [9 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[3] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[4] Univ N Carolina, Ctr Funct GI & Motil Disorders, Ctr Educ & Practice Biopsychosocial Care, Chapel Hill, NC 27515 USA
[5] Drossman Gastroenterol, Chapel Hill, NC USA
[6] Sanjay Gandhi Postgrad Inst Med Sci SGPGI, Dept Gastroenterol, Lucknow, Uttar Pradesh, India
[7] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med & Clin Nutr, Gothenburg, Sweden
[8] Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium
[9] Univ N Carolina, Ctr Funct GI & Motil Disorders, Chapel Hill, NC 27515 USA
[10] Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania
[11] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China
[12] Tohoku Univ, Dept Behav Med, Grad Sch Med, Sendai, Miyagi, Japan
[13] Univ Sydney, Northern Clin Sch, Discipline Med, Sydney, NSW, Australia
[14] Univ Jos, Jos Univ Teaching Hosp, Dept Med, Jos, Nigeria
[15] Houston Methodist Hosp, Lynda K & David M Underwood Ctr Digest Disorder G, Houston, TX 77030 USA
[16] Weill Cornell Med Coll, Houston, TX USA
[17] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Unit Res Expt Med, Lab Liver Pancreas & Motil HIPAM,Fac Med, Mexico City, DF, Mexico
[18] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Neurogastroenterol Unit, Manchester, Lancs, England
[19] Univ Ghana, Sch Med & Dent, Dept Med, Accra, Ghana
[20] Isfahan Univ Med Sci, Integrat Funct Gastroenterol Res Ctr, Sch Med, Dept Internal Med, Esfahan, Iran
[21] Israelit Hosp, Dept Med, Hamburg, Germany
[22] Univ Amsterdam, Emma Childrens Hosp, Pediat Gastroenterol, Amsterdam UMC, Amsterdam, Netherlands
[23] CHU Grenoble Alpes, Serv Hepatogastroenterol, Grenoble, France
[24] Ege Univ, Div Gastroenterol, Sch Med, Bornova, Turkey
[25] Ctr Med Dr Bustos Fernandez, Buenos Aires, DF, Argentina
[26] Wonkwang Univ, Sch Med, Dept Gastroenterol, Iksan, South Korea
[27] Ist Clin Humanitas, Dept Gastroenterol, Rozzano, Italy
[28] Univ Fed Rio Grande do Sul, Dept Internal Med, Gastroenterol Div, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[29] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Gastroenterol Unit, Bogota, Colombia
[30] Moscow State Univ Med & Dent, Fac Internal Med, Dept Outpatient Med, Moscow, Russia
[31] Univ Sains Malaysia, Sch Med Sci, Kota Baharu, Kelantan, Malaysia
[32] Wroclaw Med Univ, Dept Gastroenterol & Hepatol, Wroclaw, Poland
[33] Dhaka Med Coll & Hosp, Dhaka, Bangladesh
[34] Autonomous Univ Barcelona, Univ Hosp Vall dHebron, Dept Gastroenterol, Barcelona, Spain
[35] Vall dHebron Res Inst, Neuroinmunogastroenterol Lab, Barcelona, Spain
[36] Univ Cape Town, Dept Med, Div Gastroenterol, Cape Town, South Africa
[37] Univ Indonesia, Cipto Mangunkusumo Hosp, Fac Med, Dept Internal Med,Div Gastroenterol, Jakarta, Indonesia
[38] Queens Univ, Kingston Hlth Sci Ctr, Gastrointestinal Dis Res Unit, Kingston, ON, Canada
[39] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[40] UMAE Hosp Especialidades CMN Manuel Avila Camacho, Puebla, Pue, Mexico
[41] Sackler Sch Med, Rabin Med Ctr, Div Gastroenterol, Tel Aviv, Israel
[42] Univ Alberta, Dept Med, CEGIIR Div Gastroenterol, Edmonton, AB, Canada
[43] Mazandaran Univ Med Sci, Gut & Liver Res Ctr, Dept Internal Med, Sari, Iran
[44] Univ Montreal, CHUM, Montreal, PQ, Canada
[45] KIMS Hosp, Secunderabad, India
[46] Natl Med Res Ctr Prevent Med, Dept Biochem Markers Chron Noncommunicable Dis Re, Moscow, Russia
关键词
DGBI; IBS; epidemiology; IRRITABLE-BOWEL-SYNDROME; IV DIAGNOSTIC QUESTIONNAIRE; RISK-FACTORS; SEVERITY; CRITERIA;
D O I
10.1053/j.gastro.2020.04.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Although functional gastrointestinal disorders (FGIDs), now called disorders of gut-brain interaction, have major economic effects on health care systems and adversely affect quality of life, little is known about their global prevalence and distribution. We investigated the prevalence of and factors associated with 22 FGIDs, in 33 countries on 6 continents. METHODS: Data were collected via the Internet in 24 countries, personal interviews in 7 countries, and both in 2 countries, using the Rome IV diagnostic questionnaire, Rome III irritable bowel syndrome questions, and 80 items to identify variables associated with FGIDs. Data collection methods differed for Internet and household groups, so data analyses were conducted and reported separately. RESULTS: Among the 73,076 adult respondents (49.5% women), diagnostic criteria were met for at least 1 FGID by 40.3% persons who completed the Internet surveys (95% confidence interval [CI], 39.9-40.7) and 20.7% of persons who completed the household surveys (95% CI, 20.2-21.3). FGIDs were more prevalent among women than men, based on responses to the Internet survey (odds ratio, 1.7; 95% CI, 1.6-1.7) and household survey (odds ratio, 1.3; 95% CI, 1.3-1.4). FGIDs were associated with lower quality of life and more frequent doctor visits. Proportions of subjects with irritable bowel syndrome were lower when the Rome IV criteria were used, compared with the Rome III criteria, in the Internet survey (4.1% vs 10.1%) and household survey (1.5% vs 3.5%). CONCLUSIONS: In a large-scale multinational study, we found that more than 40% of persons worldwide have FGIDs, which affect quality of life and health care use. Although the absolute prevalence was higher among Internet respondents, similar trends and relative distributions were found in people who completed Internet vs personal interviews.
引用
收藏
页码:99 / +
页数:19
相关论文
共 34 条
[1]  
[Anonymous], 2004, ALIMENT PHARM THER, DOI DOI 10.1111/j.1365-2036.2004.01897.x
[2]   How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors [J].
Aziz, Imran ;
Tornblom, Hans ;
Palsson, Olafur S. ;
Whitehead, William E. ;
Simren, Magnus .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (07) :1017-1025
[3]   Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria [J].
Black, Christopher J. ;
Yiannakou, Yan ;
Houghton, Lesley A. ;
Ford, Alexander C. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (02) :392-+
[4]   Review article: the economic impact of the irritable bowel syndrome [J].
Canavan, C. ;
West, J. ;
Card, T. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (09) :1023-1034
[5]   TRANSLATABILITY EVALUATION OF THE ROME IV DIAGNOSTIC QUESTIONNAIRE FOR ADULTS [J].
Crane, A. L. ;
Popielnicki, A. ;
Sperber, A. D. ;
Drossman, D. ;
Palsson, O. S. ;
Whitehead, W. E. ;
Sweeney, E. ;
O'Brien, K. .
VALUE IN HEALTH, 2016, 19 (07) :A389-A389
[6]   UNITED-STATES HOUSEHOLDER SURVEY OF FUNCTIONAL GASTROINTESTINAL DISORDERS - PREVALENCE, SOCIODEMOGRAPHY, AND HEALTH IMPACT [J].
DROSSMAN, DA ;
LI, ZM ;
ANDRUZZI, E ;
TEMPLE, RD ;
TALLEY, NJ ;
THOMPSON, WG ;
WHITEHEAD, WE ;
JANSSENS, J ;
FUNCHJENSEN, P ;
CORAZZIARI, E ;
RICHTER, JE ;
KOCH, GG .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (09) :1569-1580
[7]  
Drossman DA, 2016, Functional Gastrointestinal Disorders Fouth Edition, V4th, P1
[8]   Irritable bowel syndrome [J].
Enck, Paul ;
Aziz, Qasim ;
Barbara, Giovanni ;
Farmer, Adam D. ;
Fukudo, Shin ;
Mayer, Emeran A. ;
Niesler, Beate ;
Quigley, Eamonn M. M. ;
Rajilic-Stojanovic, Mirjana ;
Schemann, Michael ;
Schwille-Kiuntke, Juliane ;
Simren, Magnus ;
Zipfel, Stephan ;
Spiller, Robin C. .
NATURE REVIEWS DISEASE PRIMERS, 2016, 2 :1-24
[9]   Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis [J].
Ford, Alexander C. ;
Marwaha, Avantika ;
Sood, Ruchit ;
Moayyedi, Paul .
GUT, 2015, 64 (07) :1049-1057
[10]   The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress [J].
Francis, CY ;
Morris, J ;
Whorwell, PJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) :395-402